Dimensional Fund Advisors LP boosted its stake in CIGNA Co. (NYSE:CI) by 29.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,938,791 shares of the health services provider’s stock after purchasing an additional 440,063 shares during the quarter. Dimensional Fund Advisors LP’s holdings in CIGNA were worth $403,708,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently modified their holdings of CI. Veritas Asset Management LLP boosted its position in shares of CIGNA by 81.1% during the 2nd quarter. Veritas Asset Management LLP now owns 4,422,200 shares of the health services provider’s stock valued at $751,553,000 after acquiring an additional 1,979,877 shares during the last quarter. Ruffer LLP bought a new stake in shares of CIGNA during the 3rd quarter valued at about $302,517,000. FMR LLC boosted its position in shares of CIGNA by 18.6% during the 3rd quarter. FMR LLC now owns 8,970,440 shares of the health services provider’s stock valued at $1,868,093,000 after acquiring an additional 1,409,335 shares during the last quarter. DNB Asset Management AS boosted its position in shares of CIGNA by 533.9% during the 3rd quarter. DNB Asset Management AS now owns 578,488 shares of the health services provider’s stock valued at $120,470,000 after acquiring an additional 487,229 shares during the last quarter. Finally, Renaissance Technologies LLC raised its holdings in shares of CIGNA by 150.1% during the 2nd quarter. Renaissance Technologies LLC now owns 788,000 shares of the health services provider’s stock valued at $133,921,000 after buying an additional 472,900 shares in the last quarter. Institutional investors and hedge funds own 89.94% of the company’s stock.
A number of equities analysts recently weighed in on the company. Zacks Investment Research reissued a “strong-buy” rating and set a $246.00 price objective on shares of CIGNA in a report on Monday, November 12th. Leerink Swann raised their price objective on CIGNA from $250.00 to $260.00 and gave the company an “outperform” rating in a report on Monday, November 19th. BMO Capital Markets raised their price objective on CIGNA from $220.00 to $230.00 and gave the company a “hold” rating in a report on Friday, November 2nd. Citigroup raised their price objective on CIGNA from $243.00 to $249.00 and gave the company a “buy” rating in a report on Friday, November 2nd. Finally, Barclays raised their price objective on CIGNA from $228.00 to $235.00 and gave the company an “overweight” rating in a report on Friday, November 2nd. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $236.29.
Shares of CIGNA stock opened at $211.16 on Monday. The company has a market capitalization of $51.42 billion, a price-to-earnings ratio of 20.19, a P/E/G ratio of 1.19 and a beta of 0.58. CIGNA Co. has a one year low of $163.02 and a one year high of $227.13. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.98 and a current ratio of 0.98.
CIGNA (NYSE:CI) last issued its quarterly earnings data on Thursday, November 1st. The health services provider reported $3.84 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.45 by $0.39. The firm had revenue of $11.45 billion for the quarter, compared to analyst estimates of $11.19 billion. CIGNA had a return on equity of 23.31% and a net margin of 6.15%. The business’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period last year, the company earned $2.83 EPS. As a group, equities analysts expect that CIGNA Co. will post 14.35 EPS for the current fiscal year.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Featured Story: Asset Allocation and Your Retirement
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.